拔管后吞咽障碍患者言语治疗启动时机与结局的关联:一项多中心回顾性队列研究
该多中心回顾性队列研究纳入日本8个ICU中年龄≥20岁、经口气管插管机械通气超过48小时、因拔管后吞咽障碍(改良饮水试验评分≤3分)接受言语治疗的患者272例。主要结局为出院时吞咽障碍(功能性经口摄食量表评分<5分)或拔管后死亡,共82例(30.1%)发生,拔管至言语治疗启动时间跨度为1.0天。多因素logistic回归显示,拔管后言语治疗每延迟1天,出院时吞咽障碍或死亡风险增加(AOR 1.09,95%CI 1.02-1.18),拔管后第7天(AOR 1.28,95%CI 1.05-1.55)、第14天(AOR 1.34,95%CI 1.13-1.58)、第28天(AOR 1.21,95%CI 1.07-1.36)吞咽障碍或死亡及吸入性肺炎(AOR 1.09,95%CI 1.02-1.17)风险亦增加,但住院死亡率未受影响(AOR 1.04,95%CI 0.97-1.12)。作者认为早期启动言语治疗可能预防拔管后此并发症,需随机对照研究验证。
要点
- 每延迟1天启动言语治疗,出院时吞咽障碍或死亡风险增加(AOR 1.09,95%CI 1.02-1.18)。
- 延迟启动与拔管后第7天(AOR 1.28,95%CI 1.05-1.55)、第14天(AOR 1.34,95%CI 1.13-1.58)、第28天(AOR 1.21,95%CI 1.07-1.36)吞咽障碍或死亡相关。
- 延迟启动与吸入性肺炎发生相关(AOR 1.09,95%CI 1.02-1.17)。
- 延迟启动未影响住院死亡率(AOR 1.04,95%CI 0.97-1.12)。
- 272例中82例(30.1%)出院时存在吞咽障碍或死亡,拔管至言语治疗启动时间跨度为1.0天。
适用人群与场景
- 日本8个ICU中年龄≥20岁、经口气管插管机械通气超过48小时、因拔管后吞咽障碍接受言语治疗的患者。
- 拔管后吞咽障碍定义为改良饮水试验评分≤3分。
诊断标准与关键阈值
- 拔管后吞咽障碍定义:改良饮水试验评分≤3分。
- 出院时吞咽障碍定义:功能性经口摄食量表评分<5分。
研究设计与关键结果
- 多中心回顾性队列研究,纳入日本8个ICU的272例患者,主要结局为出院时吞咽障碍(功能性经口摄食量表评分<5分)或拔管后死亡,共82例(30.1%)发生,拔管至言语治疗启动时间跨度为1.0天。
- 拔管后言语治疗每延迟1天,出院时吞咽障碍或死亡风险增加(AOR 1.09,95%CI 1.02-1.18)。
- 拔管后言语治疗每延迟1天,拔管后第7天吞咽障碍或死亡风险增加(AOR 1.28,95%CI 1.05-1.55)。
- 拔管后言语治疗每延迟1天,拔管后第14天吞咽障碍或死亡风险增加(AOR 1.34,95%CI 1.13-1.58)。
- 拔管后言语治疗每延迟1天,拔管后第28天吞咽障碍或死亡风险增加(AOR 1.21,95%CI 1.07-1.36)。
- 拔管后言语治疗每延迟1天,吸入性肺炎风险增加(AOR 1.09,95%CI 1.02-1.17)。
- 拔管后言语治疗每延迟1天未影响住院死亡率(AOR 1.04,95%CI 0.97-1.12)。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,早期启动言语治疗可能预防拔管后吞咽障碍或死亡这一并发症。
- 作者指出,需要随机对照研究验证这些结果。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Post-extubation dysphagia (PED) is recognized as a common complication in the intensive care unit (ICU). Speech and language therapy (SLT) can potentially help improve PED; however, the impact of the timing of SLT initiation on persistent PED has not been well investigated. This study aimed to examine the timing of SLT initiation and its effect on patient outcomes after extubation in the ICU.
METHODS: We conducted this multicenter, retrospective, cohort study, collecting data from eight ICUs in Japan. Patients aged ≥ 20 years with orotracheal intubation and mechanical ventilation for longer than 48 h, and those who received SLT due to PED, defined as patients with modified water swallowing test scores of 3 or lower, were included. The primary outcome was dysphagia at hospital discharge, defined as functional oral intake scale score < 5 or death after extubation. Secondary outcomes included dysphagia or death at the seventh, 14th, or 28th day after extubation, aspiration pneumonia, and in-hospital mortality. Associations between the timing of SLT initiation and outcomes were determined using multivariable logistic regression.
RESULTS: A total of 272 patients were included. Of them, 82 (30.1%) patients exhibited dysphagia or death at hospital discharge, and their time spans from extubation to SLT initiation were 1.0 days. The primary outcome revealed that every day of delay in SLT initiation post-extubation was associated with dysphagia or death at hospital discharge (adjusted odds ratio (AOR), 1.09; 95% CI, 1.02-1.18). Similarly, secondary outcomes showed associations between this per day delay in SLT initiation and dysphagia or death at the seventh day (AOR, 1.28; 95% CI, 1.05-1.55), 14th day (AOR, 1.34; 95% CI, 1.13-1.58), or 28th day (AOR, 1.21; 95% CI, 1.07-1.36) after extubation and occurrence of aspiration pneumonia (AOR, 1.09; 95% CI, 1.02-1.17), while per day delay in post-extubation SLT initiation did not affect in-hospital mortality (AOR, 1.04; 95% CI, 0.97-1.12).
CONCLUSIONS: Delayed initiation of SLT in PED patients was associated with persistent dysphagia or death. Early initiation of SLT may prevent this complication post-extubation. A randomized controlled study is needed to validate these results.
参考来源
- Hongo T, Yamamoto R, Liu K, et al. Association between timing of speech and language therapy initiation and outcomes among post-extubation dysphagia patients: a multicenter retrospective cohort study. Crit Care. 2022. PMID: 35395802. doi:10.1186/s13054-022-03974-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。